Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 1069114-13-1
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2S)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]urea features a sterically encumbered urea core flanked by electron-deficient aryl and polycyclic heteroaryl moieties. This configuration enables robust target engagement in kinase inhibition studies, offering enhanced binding affinity and metabolic stability under physiological conditions.
N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2S)-2-[(11bR)-3,5-dihydro-4H-dinaphth[2,1-c:1',2'-e]azepin-4-yl]cyclohexyl]urea serves as a versatile building block in medicinal chemistry, enabling the construction of complex heterocyclic scaffolds through standard urea coupling protocols. Its trifluoromethylated aryl group enhances metabolic stability and lipophilicity, while the rigid dinaphthazepine core provides defined spatial orientation for target engagement. The molecule exhibits excellent bench stability and facilitates purification via standard chromatographic methods, making it well-suited for iterative synthesis campaigns in API development.
|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: